Promoting Open Access to Exploring the Research

Status of drug resistance in tuberculosis after the introduction of rifampicin in India.

Paramasivan, C N (2003) Status of drug resistance in tuberculosis after the introduction of rifampicin in India. Journal of Indian Medical Association, 101 (3). pp. 154-156. ISSN 0019-5847

[img]
Preview
PDF
200313.pdf - Published Version

Download (354kB)
Official URL: http://www.jima.in/online-journal.html

Abstract

The current threat in tuberculosis treatment lies on the fact of emergence of strains resistant to two most antituberculous drugs, isoniazid and rifampicin. Drug resistance to TB may be classified as primary and acquired. Causes of drug resistance are inefficient administration of effective treatment, poor case handling, use of sub-standad drugs, ignorance of healthcare workers, etc. Multidrug resistant TB (MDR-TB) prevalence (median) in new case is highest (14.1%) in Estonia. Studies undertaken in different regions in India by Tuberculosis Research Centre (TRC) during 1997-2000 revealed acquired MDR-TB resistance levels of 25- 100%. The key to successful prevention of the emergence of drug resistance remains adequate case finding, prompt and correct diagnosis and effective treatment of infective patients.

NIRT Creators:
NIRT CreatorsEmail
Item Type: Article
Uncontrolled Keywords: Drug resistance, multidrug resistant tuberculosis (MDR-TB), prevalence
Subjects: Tuberculosis > Laboratory Research > Bacteriological
Divisions: Basic Science Research > Bacteriology
Depositing User: Dr. Rathinasabapati R
Date Deposited: 12 Nov 2013 11:23
Last Modified: 09 Mar 2016 10:57
URI: http://eprints.nirt.res.in/id/eprint/607

Actions (login required)

View Item View Item